Grade: L2 Location: Cataluña Job type: Permanent, Full-time About the job At Sanofi, we are driven by one purpose – we chase the miracles of science to improve people's lives.
Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.
We never settle and now we are creating a new paradigm with a first-in-class therapy in Autoimmune Diabetes (Type 1 Diabetes).
Our newest core asset, resulting from the acquisition of Provention Bio in General Medicines Autoimmune Type 1 Diabetes space, aims at delaying the onset of stage 3 type 1 diabetes.
This means that for the first time, people at risk of developing this lifelong disease have fresh hope.
What delayed onset means is more time for children to be children with less healthcare and more care-free childhood.
The delay also gives families and healthcare professionals more time to prepare care plans for a later diagnosis.
We now present an exciting opportunity for you to go further faster.
If you're excited by the prospect of bringing this innovative, first-in-class therapy to more people at risk then we want to hear from you as we build a great team who will work at the intersection of our growth in immune-mediated diseases and disease-modifying therapies in areas of high unmet need.
This really is a 'prime time' role offering you huge visibility and the chance to fast-track your career in healthcare.
Innovation, patient focus and disruptive thinking are all key threads of our Play To Win culture.
Our Autoimmune Type 1 Diabetes journey starts now and you can help us chart a new course – not only for Sanofi but for preventive healthcare.
Our Team: We are seeking a highly motivated and visionary leader interested in shaping the management of people at risk of developing/or with T1 diabetes.
As a MSL, you will be the trusted scientific partner in the field for external experts and decision-makers (incl.
KOLs, Endos, other scientific stakeholders) engaging in mutual scientific exchanges to accelerate data dissemination on a first-in-class therapy in Autoimmune Type 1 Diabetes.
You will be primarily responsible to enhance the understanding of the scientific and medical value of our innovative product in the therapeutic area.
Reporting to Medical Lead Type 1 Autoimmune Diabetes, this role is strategically positioned to realize the ambition for T1D and contribute to the overall future success of Sanofi.
Your core responsibilities will include: Being the trusted scientific partner to key external experts (incl.
KOLs, Endos, other scientific stakeholders), establishing and maintaining robust, long-term peer relationships.
Conducting high-touch scientific exchange with experts from key accounts (e.g., KOLs in Centers of Excellence) and beyond.
#J-18808-Ljbffr
